MotherToBaby

Medications and More during pregnancy and breastfeeding

Buscar

866.626.6847

Metoclopramide

Selected References

  • Allen RW. 2012. Metoclopramide–a safe anti-emetic? [letter] S Afr Med J; 77: 219, 1990.
  • Anderka M, et al. 2012. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res (Part A); 94:22-30.
  • Andersen AN, Tabor A. 1982. Prl, TSH, GH and LH responses to metoclopramide and breastfeeding in normal and hyperprolactinaemic women. Acta Endocrinol (Copenh); 100:177-83.
  • Balikci A, Balibey H. 2012. [Postpartum depression due to use of metoclopramide: A case report]. Anatolian J Clin Invest; 6:258-60.
  • Bérard A, et al. 2019. New Evidence for Concern Over the Risk of Birth Defects from Medications for Nausea and Vomiting of Pregnancy. J Clin Epidemiol; 116: 39-48.
  • Berkovitch M, et al. 2002. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study. Am J Perinatol; 19:311-6.
  • Çekmez Y, et al. 2016. Does metroclopramide exposure alter endometrial receptivity and decrease pregnancy rates? J Matern Fetal Neonatal Med 29(16): 2703-6
  • Dastgerdi E, et al. 2011. Effect of metoclopramide on increased milk production in mothers of preterm infants. Iran J Obstet Gynecol Infertil; 14:32-6.
  • Fife S, et al. 2011. Metoclopramide to augment lactation, does it work? A randomized trial. J Matern Fetal Neonatal Med; 24:1317-20.
  • Finnis WA, et al. 1976. Metoclopramide hydrochloride and galactorrhea. Can Med Assoc J; 115:845.
  • Foong, S. C, et al. 2020. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. The Cochrane database of systematic reviews, 5(5), CD011505.
  • Ingram J, et al. 2012. Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed; 97:F241-5.
  • Kauppila A, et al. 1981. Metoclopramide increases prolactin release and milk secretion in puerperium without stimulating the secretion of thyrotropin and thyroid hormones. J Clin Endocrinol Metab; 52:436-9.
  • Kauppila A, et al. 1983. Metoclopramide and breast feeding: transfer into milk and the newborn. Eur J Clin Pharmacol; 25:819-23.
  • Kauppila A, et al. 1985. Metoclopramide and breast feeding: efficacy and anterior pituitary responses of the mother and the child. Eur J Obstet Gynecol Reprod Biol; 19:19-22.
  • Lewis PJ, et al. 1980. Controlled trial of metoclopramide in the initiation of breast feeding. Br J Clin Pharmacol; 9:217-9.
  • Matok I, et al. 2009. The Safety of Metoclopramide Use in the First Trimester of Pregnancy. N Engl J Med; 360:2528-2535.
  • Milo R, et al. 1989. Acute intermittent porphyria in pregnancy. Obstet Gynecol 73:450-2.
  • Nageotte MP, et al. 1996. Droperidol and diphenhydramine in the management of hyperemesis gravidarum. Am J Obstet Gynecol; 174:1801-1805.
  • Negro, A, et al. 2021. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency. Blood pressure, 30(5), 322–326.
  • Pasternak B, et al. 2013. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA. 310(15):1601-11.
  • Sakha R, Behbahan AG. 2008. Training for perfect breastfeeding or metoclopramide: which one can promote lactation in nursing mothers? Breastfeed Med; 3:120-3.
  • Shen Q, et al. 2021. Efficacy and safety of domperidone and metoclopramide in breastfeeding: A systematic review and meta-analysis. Breastfeed Med. 16:516–29.
  • Shenhav S, et al. 1997. Acute intermittent porphyria precipitated by hyperemesis and metoclopramide treatment in pregnancy. Acta Obstet Gynecol Scand;76:484-5.
  • Suarez, E. A et al. 2021. Ondansetron use in early pregnancy and the risk of miscarriage. Pharmacoepidemiology and drug safety, 30(2), 103–113.
  • Sun, L, et al. 2021. Use of metoclopramide in the first trimester and risk of major congenital malformations: A systematic review and meta-analysis. PloS one, 16(9), e0257584.
  • Tabrizi SO, et al. 2017. The effect of metoclopramide on prolactin levels in breastfeeding mothers: A systematic review and meta-analysis. Int J Pediatr (Mashhad). 5:5827–38.
  • Winterfeld U, et al. 2012. Management of deficient lactation in Switzerland and Canada: A survey of midwives’ current practices. Breastfeed Med. 2012;7:317–8.

MotherToBaby cuenta con el apoyo de la Administración de Recursos y Servicios de Salud (HRSA) del Departamento de Salud y Servicios Humanos de los Estados Unidos (HHS) como parte de una adjudicación por un total de $6,000,000 con cero porcentaje financiado con fuentes no gubernamentales. Los contenidos son los del autor/es y no representan necesariamente los puntos de vista oficiales de, ni un respaldo, por HRSA, HHS o el Gobierno de los Estados Unidos.